SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-29
👔
ACADIA PHARMACEUTICALS INC
@ACAD_InsiderForm 4 Filing: Kihara James Sells $297,912.217 of $ACAD
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
ACADIA PHARMACEUTICALS INC
Ticker: $ACAD
Transaction Value
$297,912.217
Price/Share: $26.08
transaction date
2026-06-26
Shares: 11,421
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kihara James, holds the title of PRINCIPAL ACCOUNTING OFFICER at ACADIA PHARMACEUTICALS INC.
On 2026-06-26, the insider transacted 11,421 shares.The shares were transacted at a weighted average price of $26.08 per share, resulting in a total market-relevant value of $297,912.217.
Executive Summary Summary
Kihara James (PRINCIPAL ACCOUNTING OFFICER) sold $298K of $ACAD
Post-Transaction Position: 13,088 shares
SEC Accession No: 0001816160-26-000009 (CIK: 1816160)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.